Pharmaceuticals

Outlook for Hepatitis Patients Set to Improve with Development of Accessible Treatments

PHILADELPHIA, July 28, 2014 /PRNewswire/ -- The Intellectual Property and Science Business of Thomson Reuters , the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatit...

2014-07-28 21:09 1503

Action Needed ASAP to Fight Viral Hepatitis

SINGAPORE, July 25, 2014 /PRNewswire/ -- The Coalition to Eradicate Viral Hepatitis inAsia Pacific (CEVHAP) is, in advance of World Hepatitis Day on 28 July 2014, calling upon governments across Asia-Pacific to develop and implement coordinated national action plans to fight viral hepatitis. Vira...

2014-07-25 09:00 1658

TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform

TEANECK, N.J., July 24, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been selected byTransCelerate BioPharma Inc. , a non-profit organization with membership representation from 19 major pharmaceu...

2014-07-24 18:00 1698

Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials

PHILADELPHIA, July 22, 2014 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters , the world's leading provider of intelligent information for businesses and professionals, today announcedCortellis Clinical Trials Intelligence <...

2014-07-22 22:05 1419

AMRI to Announce Second Quarter Results

ALBANY, New York, July 22, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue second quarter financial results before the opening of the market onTuesday, August 5, 2014.  Following the release of its results, the company will host a conference call and simultaneous audio we...

2014-07-22 20:00 1033

Hopp Acquires LTS Shares From Novartis & BWK

ANDERNACH, Germany, July 17, 2014 /PRNewswire/ -- - LTS: market leader in transdermal patches completely acquired by dievini Hopp The supervisory board ("Aufsichtsrat") and management board ("Vorstand") of LTS have concluded the assessment of strategic options for the future development of the...

2014-07-17 20:36 1767

CPhI Panel to Analyse New Industry Perspectives and Innovations Ahead of Predictive 2014 Annual Report

AMSTERDAM, July 16, 2014 /PRNewswire/ -- New panel additions Patheon, Almac and Arevepharma to provide global insights from the contract services sector  CPhI expert panel members for 2014:  * Prabir Basu, President at Pharma Manufacturing * Girish Malhotra, President & Founder, Epcot I...

2014-07-16 20:43 1194

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)

REDWOOD CITY, Calif., July 16, 2014 /PRNewswire/ -- Coherus BioSciences , Inc. announced the start of its Phase 3 trial of CHS-0214, a proposed biosimilar of etanercept (Enbrel®), in chronic plaque psoriasis (the RaPsOdy trial). This announcement follows the recent init...

2014-07-16 20:00 1708

Aptuit Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities

GREENWICH, Conn., July 16, 2014 /PRNewswire/ -- Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit's sales and marketing activities. Jonathan Goldman, M.D., Aptuit's Chief Executive Officer, s...

2014-07-16 02:20 1246

CEM's Breakthrough High-Efficiency Peptide Synthesis Technology Wins R&D 100 Award

MATTHEWS, N.C., July 15, 2014 /PRNewswire/ -- CEM Corporation , a leading provider of microwave laboratory instrumentation, is pleased to announce that theLiberty Blue™ Automated Microwave Peptide Synthesizer is a winner of a2014 R&D 10...

2014-07-15 21:00 1488

Dmitry Medvedev Presented BIOCAD the First National "Industry" Award

ST. PETERSBURG, Russia, July 15, 2014 /PRNewswire/ -- On July 9 Prime Minister of the Russian FederationDmitry Medvedev, presented Russia's first national "Industry" award to a biopharmaceutical companyBIOCAD . The Company is developing a unique project called MabNext. Withi...

2014-07-15 09:00 978

Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan

ABBOTT PARK, Ill., July 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that will combine Mylan's existing business andAbbott's developed markets ph...

2014-07-14 21:41 1870

NPCB Malaysia Issues GMP Certificate to Bilcare Global Clinical Supplies

  KUALA LUMPUR, Malaysia, July 11, 2014 /PRNewswire/ -- Bilcare GCS received Certificate of GMP Compliance of Manufacturer from National Pharmaceutical Control Bureau, Ministry of Health,Malaysia. This certificate comes after going through strict inspection conducted in accordance to th...

2014-07-11 14:32 1880

Abbott and Fonterra to Form Strategic Alliance for Dairy Farming in China

ABBOTT PARK, Ill. and AUCKLAND, New Zealand, July 11, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) and Fonterra Co-operative Group Ltd today announced the signing of an agreement to develop a proposed dairy farm hub inChina. The strategic alliance, which is subject to Chinese regulatory approval, will...

2014-07-11 02:17 1605

Abbott Builds Long-Term Commitment in China

ABBOTT PARK, Ill., July 11, 2014 /PRNewswire/ -- Today's announcement of a proposed strategic alliance with Fonterra to develop dairy farms is the latest in a series of investments Abbott (NYSE: ABT) has made inChina, deepening its commitment in the country. In June, Abbott opened a state-of-the-...

2014-07-11 02:01 1437

Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors

REDWOOD CITY, Calif., July 9, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus"), announced today the appointment ofV. Bryan Lawlis, Jr., Ph.D., former President and CEO of Itero Biopharmaceuticals, to its Board of Directors. "It is a privilege to join this talented Board of Directors, an...

2014-07-09 20:00 2202

Taipei Medical University-Taipei Cancer Center Offers a New and Noninvasive Treatment for Bone Cancer Pain

TAIPEI, July 4, 2014 /PRNewswire/ -- Taipei Medical University-Taipei Cancer Center (TMU-TCC) announced today that its Taipei Cancer Center (TCC) is now offering a new technology, ExAblate, to improve the quality of life of patients suffering from painful bone metastases. Taipei Cancer Center, af...

2014-07-04 10:00 1897

AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing

ALBANY, N.Y., July 2, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners, LLC. The transaction is consistent with AMRI's strategy to be the preeminent suppli...

2014-07-02 04:22 1567

Synageva BioPharma™ Reports Positive Top-Line Results From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency

LEXINGTON, Massachusetts, July 1, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, announced today that the global, randomized, double-blind, placebo-controlled Phase ...

2014-07-01 04:02 1496

Economist Intelligence Unit Report Calls for Urgent Global Action to Combat the Growing Tuberculosis Pandemic

LONDON, June 30, 2014 /PRNewswire/ -- A new report on tuberculosis (TB) published today by The Economist Intelligence Unit (EIU) investigates the increasing health challenges posed by TB and calls for new ways to improve the effectiveness of the global response to this pandemic[1]. The report sup...

2014-06-30 20:53 1484
1 ... 979899100101